[
  {
    "ts": null,
    "headline": "Abbott (ABT) Wins FDA Approval for Volt PFA System in AFib Treatment",
    "summary": "Abbott Laboratories (NYSE:ABT) is included among the 14 Best Pharma Dividend Stocks to Buy in 2026. On December 22, Abbott Laboratories (NYSE:ABT) said the US Food and Drug Administration has approved the company’s Volt™ PFA System to treat patients with atrial fibrillation, or AFib. The company plans to begin commercial PFA cases in the United […]",
    "url": "https://finnhub.io/api/news?id=214122deaab9fac8b66fe7b3ffdad612fa8668f8b42361481b1e3e12e1d42c83",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1767134795,
      "headline": "Abbott (ABT) Wins FDA Approval for Volt PFA System in AFib Treatment",
      "id": 137948810,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "Abbott Laboratories (NYSE:ABT) is included among the 14 Best Pharma Dividend Stocks to Buy in 2026. On December 22, Abbott Laboratories (NYSE:ABT) said the US Food and Drug Administration has approved the company’s Volt™ PFA System to treat patients with atrial fibrillation, or AFib. The company plans to begin commercial PFA cases in the United […]",
      "url": "https://finnhub.io/api/news?id=214122deaab9fac8b66fe7b3ffdad612fa8668f8b42361481b1e3e12e1d42c83"
    }
  }
]